AMGEN (AMGN) Profit Margin (2008 - 2026)
AMGEN (AMGN) profit margin from Jun 30, 2008 to Mar 31, 2026. The current AMGEN (AMGN) profit margin is 21.11%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Profit Margin
Quarterly Profit Margin
Annual Profit Margin change of AMGEN (AMGN)
| Year | Profit Margin | Change |
|---|---|---|
| 2025 | 20.98% | +71.47% |
| 2024 | 12.24% | -48.64% |
| 2023 | 23.83% | -4.27% |
| 2022 | 24.89% | +9.73% |
| 2021 | 22.68% | -20.61% |
| 2020 | 28.57% | -14.88% |
| 2019 | 33.57% | -5.04% |
| 2018 | 35.35% | +308.11% |
| 2017 | 8.66% | -74.21% |
| 2016 | 33.59% | +4.85% |
| 2015 | 32.03% | +24.60% |
| 2014 | 25.71% | +370.27% |
| 2013 | 5.47% | -78.28% |
| 2012 | 25.17% | +6.47% |
| 2011 | 23.64% | -23.10% |
| 2010 | 30.74% | -2.27% |
| 2009 | 31.45% | +16.45% |
| 2008 | 27.01% | +29.61% |
| 2007 | 20.84% | N/A |
Comparison AMGEN (AMGN) profit margin with competitors
AMGEN (AMGN) profit margin is 21.11%.
| Ticker | Name | Profit Margin | Upside |
|---|---|---|---|
| NVO | Novo Nordisk | 50.15% | +137.60% |
| LLY | Lilly(Eli) & Company | 37.36% | +77.00% |
| GILD | Gilead Sciences Inc | 29.04% | +37.58% |
| NVS | Novartis AG | 23.34% | +10.58% |
| BMY | Bristol-Myers Squibb Company | 23.30% | +10.39% |
| GSK | GSK Plc | 22.77% | +7.88% |
| JNJ | Johnson & Johnson | 21.76% | +3.09% |
| AZN | Astrazeneca plc | 20.15% | -4.53% |
| PFE | Pfizer Inc | 18.59% | -11.92% |
| SNY | Sanofi | 14.35% | -32.01% |
| BIIB | Biogen Inc | 12.89% | -38.93% |
| OGN | Organon & Company | 10.00% | -52.62% |
| ABBV | Abbvie Inc | 4.63% | -78.06% |
| GRFS | Grifols SA | 4.29% | -79.67% |